Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study

INTRODUCTION: the use of palivizumab as prophylaxis of the respiratory syncytial virus is not a consensus. In Brazil, it is a public health program, but other countries do not consider it cost-effective. OBJECTIVE: to identify the rate of hospitalization in Intensive Care Unit for respiratory illnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Ivana Regina, Duarte, Marli Teresinha Cassamassimo, Nunes, Helio Rubens de Carvalho, Alencar, Rubia de Aguiar, Parada, Cristina Maria Garcia de Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614238/
http://dx.doi.org/10.1590/1518-8345.1947.2928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614238/
http://dx.doi.org/10.1590/1518-8345.1947.2928

Ejemplares similares